Clinical Trials in Leicester - 23 Recruiting Industry Studies

Recruiting Phase 3

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Weight Management
AstraZeneca · started 2026-06-29

📍 Ashton-under-Lyne · Blackpool · Chesterfield · Corby · Ely

NCT07667803 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration
EyeBiotech Ltd. · started 2026-03-27

📍 Leicester · London

NCT07440225 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Breast Neoplasms
Merck Sharp & Dohme LLC · started 2025-07-21

📍 London · Leicester · Manchester

NCT07060807 on ClinicalTrials.gov ↗

Recruiting Phase 1

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Advanced Prostate Cancer, Metastatic Prostate Cancer
Genentech, Inc. · started 2023-05-02

📍 Cambridge · Leicester · Manchester · Sutton

NCT05800665 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2025-10-08

📍 Truro · London · Birmingham · Leicester

NCT07190248 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Multiple Myeloma
GlaxoSmithKline · started 2023-06-14

📍 Leicester · Oxford · Plymouth

NCT05714839 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Merck Sharp & Dohme LLC · started 2025-04-09

📍 Cambridge · Edinburgh · London · Sutton · Leicester

NCT06824467 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Immune Thrombocytopenic Purpura (ITP)
Takeda · started 2025-08-14

📍 Leicester · Southampton · Southwark · Liverpool · Glasgow

NCT06948318 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Immune Thrombocytopenic Purpura (ITP)
Takeda · started 2025-02-27

📍 Leicester · Southampton · Southwark · Liverpool · Glasgow

NCT06722235 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

Cancer
Hoffmann-La Roche · started 2023-06-01

📍 Leicester · Surrey

NCT05862285 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Non Small Cell Lung Carcinoma
AbbVie · started 2025-03-06

📍 Leicester · Cardiff

NCT06772623 on ClinicalTrials.gov ↗

Active Phase 1

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy

Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim · started 2024-02-14

📍 Leicester

NCT05990738 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Dermatitis Atopic
Sanofi · started 2024-05-08

📍 Portsmouth · Leicester · London · Glasgow

NCT06407934 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC · started 2025-06-30

📍 London · Dundee · Huddersfield · Colchester · Orpington

NCT06966700 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

HER2-positive Breast Cancer
Hoffmann-La Roche · started 2026-05-21

📍 Leicester · London · Manchester · Sutton

NCT07413939 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Multiple Myeloma
Pfizer · started 2022-11-10

📍 Leicester · Cardiff

NCT05623020 on ClinicalTrials.gov ↗

Recruiting Phase 2/Phase 3

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Mirati Therapeutics Inc. · started 2020-12-02

📍 Birmingham · Edinburgh · Kent · Leicester · London

NCT04613596 on ClinicalTrials.gov ↗

Recruiting Phase 3

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Pediatric Migraine
Pfizer · started 2021-01-15

📍 Leicester · London

NCT04649242 on ClinicalTrials.gov ↗

Recruiting Phase 2

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Small Cell Lung Carcinoma, Neuroendocrine Neoplasms, Extra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim · started 2023-10-13

📍 Leicester · London · Manchester · Newcastle upon Tyne

NCT05882058 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Obesity, Overweight
Boehringer Ingelheim · started 2026-06-30

📍 High Wycombe · Leicester · Middlesbrough · Oxford

NCT07662122 on ClinicalTrials.gov ↗

Active

A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development

Spasticity as Sequela of Stroke
Ipsen · started 2023-11-01

📍 Leicester · Liverpool · London · Middlesbrough · Nottingham

NCT06055725 on ClinicalTrials.gov ↗

Recruiting Phase 2

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Lupus Nephritis
Novartis Pharmaceuticals · started 2022-08-10

📍 Cambridge · Leicester

NCT05268289 on ClinicalTrials.gov ↗

Recruiting Phase 1

Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer, HGSOC, HGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Epitopea Ltd · started 2026-07

📍 Cambridge · Edinburgh · Glasgow · Leeds · Leicester

NCT07665515 on ClinicalTrials.gov ↗

No trials match your search.

Browse by city

London · 118 Manchester · 30 Glasgow · 27 Cambridge · 27 Birmingham · 24 Leicester · 23 Bristol · 23 Leeds · 22 Sutton · 19 Oxford · 19 Liverpool · 18 Edinburgh · 15 Nottingham · 14 Cardiff · 14 Newcastle upon Tyne · 13 Sheffield · 12

Browse by condition

Obesity · 5 Chronic Lymphocytic Leukemia · 5 Cancer · 4 Breast Neoplasms · 3 Non-small Cell Lung Cancer · 3 Small Lymphocytic Lymphoma · 3 Multiple Myeloma · 3 Hypertension · 3 Heart Failure · 3 Triple Negative Breast Neoplasms · 2 Lymphoma, Non-Hodgkin · 2 Lymphoma, Follicular · 2 Lymphoma, Large B-Cell, Diffuse · 2 Gastric Cancer · 2 Metastatic Prostate Cancer · 2 Overweight · 2

Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/leicester (Accessed: 11 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.